Analysts' Top Healthcare Picks: Trevi Therapeutics (TRVI), Oncolytics Biotech (ONCY)

Retrieved on: 2025-03-10 14:12:29

Tags for this article:

Click the tags to see associated articles and topics

Analysts' Top Healthcare Picks: Trevi Therapeutics (TRVI), Oncolytics Biotech (ONCY). View article details on hiswai:

Excerpt

Oncolytics Biotech has an analyst consensus of Moderate Buy, with a price target consensus of $4.00. Takeda Pharmaceutical Company (TAK). In a report ...

Article found on: markets.businessinsider.com

View Original Article